Rheumatological complications of GI disorders

American Journal of Gastroenterology

Volumn 91, Issue 6, 1996, Pages 1090-1103

  Fomberstein, Barry ^a,b   Yerra, Nagarjuna ^a   Pitchumoni, C S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b OUR LADY OF MERCY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT; RHEUMATOID FACTOR;

ANKYLOSING SPONDYLITIS; BACTERIAL INFECTION; CELIAC DISEASE; CHRONIC LIVER DISEASE; CLINICAL FEATURE; ENTERITIS; HEPATITIS C VIRUS; HLA SYSTEM; HUMAN; INTESTINE LIPODYSTROPHY; INTESTINE MUCOSA PERMEABILITY; PANCREAS CARCINOMA; PANCREATITIS; PANNICULITIS; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; REACTIVE ARTHRITIS; REVIEW; SPONDYLOARTHROPATHY; SYNDROME CREST; VIRUS HEPATITIS;

ACUTE DISEASE; CHRONIC DISEASE; GASTROINTESTINAL DISEASES; HUMANS; RHEUMATIC DISEASES;

EID: 0029886306     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (200)

1. Moll JM, Haslock I, Macrae IF, et al. Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behçet's syndrome. Medicine (Baltimore) 1974; 53:343-64.
2. Lipsky PE. Spondyloarthropathies: Etiology and pathogenesis. In: Klippel JH, Dieppe PA, eds. Rheumatology. London, UK: Mosby-Yearbook Europe Limited, 1994: 261-6.
3. Mielants H, Veys E, Cuvelier C, et al. HLA-B27-related arthritis and bowel inflammation. Part 2. Ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis. J Rheumatol 1985;12:293-8.
4. Cuvelier C, Barbatis C, Mielants H, et al. Histopathology of intestinal inflammation related to reactive arthritis. Gut 1987;28:394-401.
5. Cuvelier C, Mielants H, De Vos M, et al. Immunoglobulin containing cells in terminal ileum and colorectum of patients with arthritis related gut inflammation. Gut 1988;29:916-25.
6. Mielants H, Veys EM, Goemaere S, et al. Gut inflammation in the Spondyloarthropathies: Clinical, radiologie, biologic and genetic features in relation to the type of histology. A prospective study. J Rheumatol 1991;18:1542-51.
7. Schatteman L, Mielants H, Veys EM, et al. Gut inflammation in psoriatic arthritis: A prospective ileocolonoscopic study. J Rheumatol 1995;22:680-3.
8. Mielants H, Veys EM, Goemaere S, et al. A prospective study of patients with spondyloarthropathy with special reference to HLA-B27 and to gut histology. J Rheumatol 1993;20:1353-8.
9. Mielants H, De Vos M, Goemaere S, et al. Intestinal mucosal permeability in inflammatory rheumatic diseases. Part II. Role of disease. J Rheumatol 1991;18:394-401.
10. Martinez-Gonzalez O, Cantero-Hinojosa J, Paule-Sastre P, et al. Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives. Br J Rheumatol 994;33:644-7.
11. Liu Y, Xu B, Cai X. The role of intestinal permeability in the pathogenesis of ankylosing spondylitis. Chung Hua Nei Ko Tsa Chin 1995;34:91-4 (in Chinese).
12. Ahvonen P, Sievers K, Aho K. Arthritis associated with Yersinia enterocolitica infection. Acta Rheumatol Scand 1969;15:232-53.
13. Granfors K, Jalkanen S, Von Essen R, et al. Yersinia antigens in synovial fluid cells from patients with reactive arthritis. N Engl J Med 1989;320:216-21.
14. Merilahti-Palo R, Söderstrom KO, Lahesmaa-Rantala R, et al. Bacterial antigens in synovial biopsy specimens in Yersinia-triggered reactive arthritis. Ann Rheum Dis 1991;50:87-90.
15. Granfors K, Jalkanen S, Toivanen P, et al. Bacterial lipopolysaccharide in synovial cells in Shigella triggered reactive arthritis. J Rheumatol 1992;19:500.
16. Granfors K, Jalkanen S, Lindberg AA. et al. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet 1990;335:685-8.
17. Fan PT, Yu DTY. Reiter's syndrome. In: Kelly WN, ed. Textbook of rheumatology, 4th ed. Philadelphia: WB Saunders, 1993: 961-73.
18. Wollheim FA. Enteropathic arthritis. In: Kelly WN, ed. Textbook of rheumatology, 4th ed. Philadelphia: WB Saunders, 1993: 985-97.
19. Reiter H. Über eine bisher unerkannte Spirochäteninfektion (Spiroaechatosis arthritica). Dtsch Med Wschr 1916;42:1535-6.
20. Fiessinger N, Leroy ME. Contribution a l'étude d'une epidémie de dysentérie dans la Somme (Juillet-Octobre 1916). Bull Mem Soc Hóp Paris 1916;40:2051-52.
21. Paronen J. Reiter's disease. A study of 344 cases observed in Finland. Acta Med Scand 1948;131(suppl 212):1-112.
22. Vairtiainen J, Hurri L. Arthritis due to Salmonella typhimurium. Report of 12 cases of migratory arthritis in association with Salmonella typhimuriuim infection. Acta Med Scand 1964;175:771-6.
23. Noer HR. An "experimental" epidemic of Reiter's syndrome. J Am Med Assoc 1966; 198;693-8.
24. Skirrow BM. Campylobacter enteritis: A "new" disease. Br Med J 1977;2:9-11.
25. Inman RD. Antigens, the gastrointestinal tract, and arthritis. In: Rheumatic disease clinics of North America. Philadelphia: WB Saunders, 1991: 309-21.
26. Kvien TK, Glennås A, Melby K, et al. Reactive arthritis: Incidence, triggering agents and clinical presentation. J Rheumatol 1994;21: 115-22.
27. Inman RD, Scofield RH. Etiopathogenesis of ankylosing spondylitis and reactive arthritis. Curr Opin Rheumatol 1994;6:360-70.
28. Hughes RA, Keat AC. Reiter's syndrome and reactive arthritis: A current view. Semin Arthritis Rheum 1994;24:190-210.
29. Leirisalo M, Skylv G, Kousa M, et al. Follow-up study on patients with Reiter's disease and reactive arthritis with special reference to HLA-B27. Arthritis Rheum 1982;25:249-59.
30. Nepom GT, Nepom B. The major histocompatibility complex. In: Klippel JH, Dieppe PA, eds. Rheumatology. London, UK: Mosby-Year Book Europe Limited, 1994: 12.1-.12.
31. Hermann E, Yu DT, Meyer zum Büschenfelde KH, et al. HLA-B27-restricted CD8 T-cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 1993;342(8872): 646-50.
32. Taurog JD. Genetics and immunology of the spondyloarthropathies. Curr Opin Rheumatol 1989;1:144-50.
33. Taurog JD. Immunology, genetics, and animal models of the spondyloarthropathies. Curr Opin Rheumatol 1990;2:586-91.
34. Yu DT, Choo SY, Schaack T. Molecular mimicry in HLA-B27 related arthritis. Ann Intern Med 1989;111:581-91.
35. Chen JH, Kono DH, Yong Z, et al. A Yersinia pseudo-tuberculosis protein which cross-reacts with HLA-B27. J Immunol 1987;139: 3003-11.
36. Lahesmaa R, Skurnik M, Granfors K, et al. Molecular mimicry in the pathogenesis of spondyloarthropathies: A critical appraisal of cross-reactivity between microbial antigens and HLA-B27. Br J Rheumatol 1992;31(4):221-9.
37. Hammer RE, Maika SD, Richardson JA, et al. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human B2 M: An animal model of HLA-B27 associated human disorders. Cell 1990;63:1099-12.
38. Taurog JD, Richardson JA, Croft JT, et al. The germ-free state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994;180:2359-64.
39. Inman RD, Johnston MEA, Klein MH. Analysis of serum and synovial fluid IgA in Reiter's syndrome and reactive arthritis. Clin Immunol Immunopathol 1987;43:195-203.
40. Sieper J, Brown J. Review: Pathogenesis of spondyloarthropathies: Persistent bacterial antigen autoimmunity or both? Arthritis Rheum 1995;39:1547-54.
41. Feltkamp TE. Factors involved in the pathogenesis of HLA-B27-associated arthritis. Scand J Rheumatol 1995;101(suppl):213-7.
42. Thomson GTD, DeRubeis DA, Hodge MA, et al. Post-Salmonella reactive arthritis: Late clinical sequelae in a point source cohort. Am J Med 1995;98:13-21.
43. Lauhio A, Lähdevirta J, Janes R, et al. Reactive arthritis associated with Shigella sonnei infection. Arthritis Rheum 1988;31:1190-3.
44. Young RH, McEven EG. Bacillary dysentery as the cause of Reiter's syndrome. J Am Med Assoc 1947;134:1456-9.
45. Keat A. Reiter's syndrome and reactive arthritis in perspective. N Engl J Med 1983;309:1606-15.
46. Sieper J, Braun J, Wu P, et al. The possible role of Shigella in sporadic enteric reactive arthritis. Br J Rheumatol 1993;32:582-5.
47. Brewerton DA, Caffrey M, Hart FD, et al. Ankylosing spondylitis and HLA-B27. Lancet 1973;1:904-7.
48. Friis J, Svejgaard A. Salmonella arthritis and HL-A27. Lancet 1974; 1350.
49. Berglöf FE. Arthritis and intestinal infection. Acta Rheumatol Scand 1963;9:1444-9.
50. Inman RD, Johnston MEA, Hodge M, et al. Postdysenteric reactive arthritis. A clinical and immunogenetic study following an outbreak of Salmonellosis. Arthritis Rheum 1988;31:1377-83.
51. Matlila L, Leirisalo-Repo M, Koskimies S, et al. Reactive arthritis following an outbreak of Salmonella infection in Finland. Br J Rheumatol 1994;33:1136-41.
52. Locht H, Kihlstrom E, Lindstrom FD. Reactive arthritis after Salmonella among medical doctors: Study of an outbreak. J Rheumatol 1973;20:845-8.
53. Samuel MP, Zwillich SH, Thomson GTD, et al. Fast food arthritis: A clinico-pathologic study of post-Salmonella reactive arthritis. J Rheumatol 1995;22:1947-52.
54. Mäki-Ikola O, Yli-Kerttula U, Saario R, et al. Salmonella-specific antibodies in serum and synovial fluid in patients with reactive arthritis. Br J Rheumatol 1992;31:25-9.
55. Maki-Ikola O, Leirisalo-Repo M, Kantete A, et al. Salmonella-specific antibodies in reactive arthritis. J Infect Dis 1991;164:1141-8.
56. Urmaen JD, Zurier RB, Rothfield NF. Reiter's syndrome associated with Campylobacter fetus infection. Ann Intern Med 1977;86:444-5.
57. Berden JHM, Muytjens HL, van de Putte LBA. Reactive arthritis associated with Campylobacter jejuni enteritis. Br Med J 1979;1: 380-1.5.
58. Kosunen TU, Kauranen O, Martio J, et al. Reactive arthritis after Campylobacter jejuni enteritis in patients with HLA-B27. Lancet 1980;1:1312-3.
59. Van de Putte LBA, Berden JHM, Boerbooms AMT, et al. Reactive arthritis after Campylobacter jejuni enteritis. J Rheumatol 1980;7: 531-5.
60. Kowalec JK, Kaminski ZC, Krey PR. Campylobacter arthritis. Arthritis Rheum 1980;23:92-4.
61. Leung F Y-K, Littlejohn GO, Bombardier C. Reiter's syndrome after Campylobacter jejuni enteritis. Arthritis Rheum 1980;23:948-50.
62. Gumpel JM, Martin C, Sanderson PJ. Reactive arthritis associated with Campylobacter enteritis. Ann Rheum Dis 1981;40:64-5.
63. Eastmond CJ, Rennie JAN, Reid TMS. An outbreak of Campylobacter enteritis: A rheumatological follow-up survey. J Rheumatol 1983;10:107-8.
64. Peterson MC. Rheumatic manifestations of Campylobacter jejuni and C. fetus infections in adults. Scand J Rheumatol 1994;23:167-70.
65. Aho K. Bowel infection predisposing to reactive arthritis. In: Resney PJ, ed. Baillière's clinical rheumatology, vol. 3. London: Baillière Tindall, 1989: 303-19.
66. Arvastson B, Damgaard K, Winblad S. Clinical symptoms of infection with Yersinia enterocolitica. Scand J Infect Dis 1971;3:37-40.
67. Herrlinger JD, Asmussen J-U. Long-term prognosis in Yersinia arthritis: Clinical and serological findings. Ann Rheum Dis 1992;51: 1332-4.
68. Leirisalo-Repo M, Suoranta H. Ten-year follow up study of patients with Yersinia arthritis. Arthritis Rheum 1988;31:533-7.
69. Glennas A, Kvien TK, Melby K, et al. Reactive arthritis: A favorable 2-year course and outcome, independent of triggering agent and HLA-B27. J Rheumatol 1994;21:2274-80.
70. Marsal L, Winblad S, Wollheim FA. Yersinia entero-colitica arthritis in southern Sweden: A four-year follow-up study. Br Med J 1981; 283:101-3.
71. Granfors K, Toivanen A: IgA-anti-Yersinia antibodies in Yersinia-triggered reactive arthritis. Ann Rheum Dis 1986;45:561-5.
72. Granfors K, Jalkanen S, von Essen R, et al. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med 1989;320:216-22.
73. Nikkari S, Merilahti-Palo R, Saario R, et al. Yersinia-triggered reactive arthritis: Use of polymerase chain reaction and immunocytochemical staining in the detection of bacterial components from synovial specimens. Arthritis Rheum 1992;35:682-7.
74. Viner NJ, Bailey LC, Life PF, et al. Isolation of Yersinia-specific T-cell clones from the synovial membrane and synovial fluid of a patient with reactive arthritis. Arthritis Rheum 1991;34:1151-7.
75. Probst P, Hermann E, Meyer zum Büschenfelde K-H, et al.Identification of the Yersinia enterocolitica urease B subunit as a target antigen for human synovial T lymphocytes in reactive arthritis. Infect Immunol 1993;61:4507-9.
76. Schulze-Koops H, Burkhart H, Heesemann J, et al. Characterization of the binding region for Yersinia enterocolitica adhesin Yad A on Types I and II collagen. Arthritis Rheum 1995;38:1283-9.
77. Fairweather SD, George RH, Keighley MRB, et al. Arthritis in pseudo-membranous colitis associated with an antibody to toxin. J R Soc Med 1980;73:524-5.
78. Bolton RP, Wood GM, Losowsky MS. Acute arthritis associated with Clostridiwn difficile colitis. Br Med J 1981;283:1023-4.
79. McCluskey J, Riley TV, Owen ET, et al. Reactive arthritis associated with Clostridium difficile. Aust NZ J Med 1982;12:535-7.
80. Putterman C, Rubinow A. Reactive arthritis associated with Clostridium difficile pseudomembranous colitis. Semin Arthritis Rheum 1993;22:420-6.
81. Mermel LA, Osborn TG. Clostridium difficile-associated reactive arthritis in an HLA-B27 positive female: Report and literature review. J Rheumatol 1989;16:133-5.
82. Inman RD. Arthritis and enteritis: An interface of protean manifestations. J Rheumatol 1987;14:406-10.
83. Newmark JJ, Hobbs WN, Wilson BE. Reactive arthritis associated with Hafnia alvei enteritis. Arthritis Rheum 1994;37:960.
84. Ebringer RW, Cowdell DR, Cowling P, et al. Sequential studies in ankylosing spondylitis: Association of Klebsiella pneumonia with active disease. Ann Rheum Dis 1978;37:146-51.
85. Hunter T, Harding GKM, Kaprove RE, et al. Fecal carriage of various Klebsiella and Enterobacter species in patients with active ankylosing spondylitis. Arthritis Rheum 1981;24:106-8 (letter).
86. Trull A, Ebringer R, Panagi GS, et al. IgA antibodies in ankylosing spondylitis. Scand J Rheumatol 1983;12:249-53.
87. Sahly H, Podschun R, Sass R, et al. Serum antibodies to Klebsiella capsular polysaccharides in ankylosing spondylitis. Arthritis Rheum 1994;37:754-9.
88. Schwimmbeck PL, Yu DTY, Oldstone MBA. Autoantibodies to HLA-B27 in the sera of HLA-B27 patients with ankylosing spondylitis and Reiter's syndrome: Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J Exp Med 1987;166:173-81.
89. Williams RC, Tsuchiya N, Husby G. Molecular mimicry, ankylosing spondylitis: Something missing? Scand J Rheumatol 1992;21:105-8.
90. Geczy AF, Alexander K, Bashir WV, et al. HLA-B27, Klebsiella, and ankylosing spondylitis: Biological and chemical studies. Immunol Rev 1983;70:23-50.
91. Fielder M, Pirt SJ, Tarpey I, et al. Molecular mimicry and ankylosing spondylitis: Possible role of a novel sequence in pullulanase of Klebsiella pneumoniae. FEBS Lett 1995;369:243-8.
92. Hermann E, Sucké B, Droste U, et al. Klebsiella pneumoniae-reactive T-cells in blood and synovial fluid of patients with ankylosing spondylitis. Arthritis Rheum 1995;38:1277-82.
93. Doury P, Pattin S, Dienot B, et al. Les rheumatismes parasitaires. Semin Hôp Paris 1977;53:1359-63.
94. Bocanegra TS, Espinoza LR, Bridgefold PH, et al. Reactive arthritis induced by parasitic infestation. Ann Intern Med 1981;94:207-9.
95. Akoglu T, Tuncer I, Erken E, et al. Parasitic arthritis induced by strongyloides stercoralis. Ann Rheum Dis 1984;43:523-5.
96. Woo P, Panayi GS. Reactive arthritis due to infestation with Giardia lamblia. J Rheumatol 1984;11:719.
97. Cron RQ, Sherry DD. Reiter's syndrome associated with cryptosporidial gastroenteritis. J Rheumatol 1995;22:1962-3.
98. Bargen JA. Complications and sequelae of chronic ulcerative colitis. Ann Intern Med 1930;3:335-2.
99. Wright V, Watkinson G. The arthritis of ulcerative colitis. Medicine 1959;38:243-59.
100. Weiner SR, Clare J, Taggart NA, et al. Rheumatic manifestations of inflammatory bowel disease. Semin Arthritis Rheum 1991;20:353-66.
101. Veys EM, Mielants E. Spondyloarthropathies: Enteropathic arthropathies. In: Klippel JH, Dieppe PA, eds. Rheumatology. London, UK: Mosby-Year Book Europe Limited, 1994: 351-7.
102. Haslock I, Wright V. The musculoskeletal complications of Crohn's Disease. Medicine 1973;52:217-25.
103. Van den Broek MF, van de Putte LBA, van den Berg WB. Crohn's disease associated with arthritis. A possible role for cross-reactivity between gut bacteria and cartilage in the pathogenesis of arthritis. Arthritis Rheum 1988;31:1077-9.
104. Kaufmann HJ, Taubin HL. Non-steroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann Intern Med 1987;107:513-6.
105. Leirisalo-Repo M, Turunen U, Stenman S, et al. High frequency of silent inflammatory bowel disease in spondyloarthropathy. Arthritis Rheum 1994;37:23-31.
106. Creemers MCW, van Riel PLCM, Franssen MJAM, et al. Second-line treatment in seronegative spondyloarthropathies. Semin Arthritis Rheum 1994;24:71-81.
107. Kaneoka H, Iyadomi I, Hiida M, et al. An overlapping case of ulcerative colitis and polymyositis. J Rheumatol 1990;17:274-6.
108. Jordan JM, Obeid LM, Allen NB. Isolated atlantoaxial subluxation as the presenting manifestation of inflammatory bowel disease. Am J Med 1986;80:517-20.
109. Oppenheimer DA, Jones HH. Hypertrophic osteoarthropathy of chronic inflammatory bowel disease. Skeletal Radiol 1982;9:109-13.
110. Maher JM, Strosberg JM, Rowley RF, et al. Jaccoud's arthropathy and inflammatory bowel disease. J Rheumatol 1992;19:1637-9.
111. Vakil N, Sparberg M. Steroid-related osteonecrosis in inflammatory bowel disease. Gastroenterology 1989;96:62-7.
112. Compston JE, Judd D, Crawley EO, et al. Osteoporosis in patients with inflammatory bowel disease. Gut 1987;28:410-5.
113. Payne JH, DeWind LT, Commons RP. Metabolic observations in patients with jejunocolic shunts. Am J Surg 1963;106:273-89.
114. Lewis LA, Turnbull RB, Jr, and Page IH. Effects of jejunocolic shunt on obesity, serum lipoproteins, lipids, and electrolytes. Arch Intern Med 1966;117:4-15.
115. Shagrin JW, Frame B, Duncan H. Polyarthritis in obese patients with intestinal bypass. Ann Intern Med 1971;75:377-80.
116. Zapanta M, Aldo-Benson M, Bieget A, et al. Arthritis associated with jejuno-ileal bypass. Arthritis Rheum 1979;22:711-7.
117. Delamere JP, Baddeley RM, Walton KW. Jejuno-ileal bypass arthropathy: Its clinical features and associations. Ann Rheum Dis 1983;42:553-7.
118. Dicken C. Bowel-associated dermatosis-arthritis syndrome: Bowel bypass syndrome without bowel bypass. Mayo Clin Proc 1984;59: 43-6.
119. Ely PH. The bowel bypass syndrome: A response to bacterial peptidoglycans. J Am Acad Dermatol 1980;2:473-87.
120. Bourne JT, Kumar P, Huskisson EC, et al. Arthritis and coeliac disease. Ann Rheumatol Dis 1985;44:592-8.
121. Lindstrom CG. "Collagenous colitis" with watery diarrhea: A new entity? Pathol Eur 1976; 11:87-9.
122. Castanet J, Lacour JP, Ortonne JP. Arthritis, collagenous colitis, and discoid lupus. Ann Intern Med 1994;120:89-90 (letter).
123. Erlendsson J, Fenger C, Meinicke J. Arthritis and collagenous colitis. Report of a case with concomitant chronic polyarthritis and collagenous colitis. Scand J Rheumatol 1983;12:93-5.
124. Kingsmore SF, Kingsmore DB, Hall BD, et al. Co-occurrence of collagenous colitis with seronegative spondylo-arthropathy: Report of a case and literature review. J Rheumatol 1993;20:2153-7.
125. Sowa JM. Arthritis and collagenous colitis. Ann Intern Med 1994; 121:237 (letter).
126. Relman DA, Schmidt TM, MacDermott RP, et al. Identification of the uncultured bacillus of Whipple's Disease. N Engl J Med 1992;327: 293-301.
127. Farr M, Hollywell CA, Morris CJ, et al. Whipple's disease diagnosed at hip arthroplasty. Ann Rheumatol Dis 1984;43:526-9.
128. Feurle GE, Marth T. An evaluation of antimicrobial treatment for Whipple's disease: Tetracycline versus trimethoprim-sulfamethoxazole. Dig Dis 1994;39:1642-8.
129. Caldwell DS. Musculoskeletal syndromes associated with malignancy. Arthritis Rheum 1981;10:198-223.
130. Joseph RR. Rheumatic manifestations of neoplastic disease. In: Katz WA, ed. Diagnosis and management of rheumatic diseases, 2nd ed. Philadelphia, JB Lippincott Co., 1988: 692-8.
131. MacKenzie AH, Schorbel AL. Connective tissue syndromes associated with carcinoma. Geriatrics 1963;18:745-53.
132. Graves RJ. Clinical lectures on the practice of medicine. Dublin: Fannin & Co, 1843; 446.
133. Still GF. On a form of chronic joint disease in children. Med Chir Trans 1897;80:47-60.
134. Wishart J. A link between rheumatoid arthritis and jaundice. Br Med J 1903;i:252.
135. Shumaker JB, Goldfinger SE, Alpert E, et al. Arthritis and rash: Clues to anicteric viral hepatitis. Arch Int Med 1974;133:483-5.
136. Trepo CG, Zuckerman AJ, Bird RC, et al. The role of circulating hepatitis B antigen/antibody immune complexes in the pathogenesis of vascular and hepatic manifestations in polyarteritis nodosa. J Clin Pathol 1974;27:863-8.
137. Carson CW, Conn DL, Czaja AJ, et al. Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol 1993;20:304-9.
138. Dan M, Yaniv R. Cholestatic hepatitis. Cutaneous vasculitis and vascular deposits of immunoglobulin M and complement associated with hepatitis A virus infection. Am J Med 1990;89:103-4.
139. Guillevin L, Lhote F, Leon A, et al. Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges: A prospective trial in 33 patients. J Rheumatol 1993;20:289-98.
140. Shinde M, DiBisceglie AM, Cheung L, et al. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 1991;115:700-4.
141. Bletry O, Bussel A, Badelon I, et al. Intérêt des échanges plasmatiques au cours des angeites necrosantes. 11 observations. Presse Med 1982;11:2827-31.
142. Trepo C, Ouzan D, Delmont J, et al. Superiorité d' un nouveau traitement etiopathogénique curateur des periarterites noueuses (PAN) induites par le virus de l'hépatite B grace à l'association: Corticothérapie brève, vidarabine, échanges plasmatiques. Presse Med 1988;17:1427-31.
143. Lam KC, Lai CL, Trepo C, et al. Deleterious effects of prednisone in HBS-Ag-positive chronic hepatitis. N Engl J Med 1981;304:380-6.
144. Popp JW, Dienstag JL, Wands JR, et al. Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection. Ann Intern Med 1980;92:379-83.
145. Gorevic PD, Kassab HJ, Levo Y, et al. Mixed cryoglobulinemia: Clinical aspects and long-term follow-up of 40 patients. Am J Med 1980;69:287-308.
146. Brouet JC, Clauvel JP, Danon F, et al. Biologic and clinical significance of cryoglobulins: A report of 80 cases. Am J Med 1974;57: 775-88.
147. Fernandez SM, Barbado FJ, Mola EM, et al. Evidence of hepatitis C virus antibodies in the cryoprecipitate of patients with mixed cryoglobulinemia. J Rheumatol 1994;21:229-33.
148. Ferri C, Greco F, Longombardo G, et al. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum 1991; 34:1606-10.
149. McIntosh RM, Griswold WR, Chernack WB, et al. Cryoglobulins III. Further studies on the nature, incidence, diagnostic, prognostic and immunopathogenic significance of cryoprotein in renal disease. Q J Med 1975;44:285.
150. Mariette X, Gozlan J, Clera D, et al. Detection of Epstein-Barr virus DNA by in situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjögren's syndrome. Am J Med 1991;90:286-94.
151. Coudere LJ, D'Agay MF, Danon F, et al. Sicca complex and infection with human immunodeficiency virus. Arch Int Med 1987;147:898-901.
152. Flescher E, Talal N. Do viruses contribute to the development of Sjögren's syndrome? Am J Med 1991;90:283-4.
153. Dusheika GM, Smith M, Scheuer PJ. Hepatitis C virus transmitted by human bite. Lancet 1990;336:503-4.
154. Haddad J, Deny P, Munz-Gotheil C, et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992;339:321-3.
155. Morris EL, Stevens MB. Rheumatoid arthritis: A sequel to HBsAg hepatitis. Am J Med 1978;64:859-62.
156. Tanaka K, Kobayashi S, Isobe Y, et al. Anti-hepatitis C virus antibody in sera from patients with rheumatic diseases. Presented at the 34th Meeting of the Japan Rheumatism Association, Osaka, Japan, 1990 (abstract) (in Japanese).
157. Ohta N, Nishimura YK, Tanimoto K, et al. Association between HLA and Japanese patients with rheumatoid arthritis. Hum Immunol 1982; 5:123-32.
158. Mackay IR, Wood IJ. Lupoid hepatitis: A comparison of cases with other types of chronic liver disease. Q J Med 1962;31:485-507.
159. Mackay IR, Weiden S, Hasker J. Autoimmune hepatitis. Ann NY Acad Sci 1965;124:767-80.
160. Wallace DJ. Gastrointestinal manifestations and related liver and biliary disorders. In: Wallace DJ, Hahn BH, eds. Dubois lupus erythematosus. Philadelphia: Lea and Febiger, 1993: 415-7.
161. Selby CL, Utsinger PD. Gastrointestinal and abdominal manifestations. In: Katz WA, ed. Diagnosis and management of rheumatic diseases, 2nd ed. Philadelphia: JB Lippincott Co., 1988: 211-9.
162. Czaja AJ. Autoimmune hepatitis: Evolving concepts and treatment strategies. Dig Dis Sci 1995;40:435-56.
163. Johnson PJ, McFarlane IG, Alvarez F, et al. Meeting report of the International Autoimmune Hepatitis Group. Hepatology 1993;18: 998-1005.
164. Homberg JC, Abuaf N, Bernard O, et al. Chronic active hepatitis associated with anti-liver/kidney microsome antibody type I: A second type of "autoimmune" hepatitis. Hepatology 1987;7:1333-9.
165. Lenzi M, Ballardini G, Fusconi M, et al. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 1990;335:258-9.
166. Manns M, Gerhon G, Kyriatsoulis A, et al. Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet 1987;1:292-4.
167. Clark AK, Galbraith RM, Hamilton EBD, et al. Rheumatic disorders in primary biliary cirrhosis. Ann Rheum Dis 1978;37:42-7.
168. Culp KS, Flemming CR, Duffy J, et al. Autoimmune association in primary biliary cirrhosis. Mayo Clin Proc 1982;57:365-70.
169. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1987;316: 521-8.
170. Akama M, Yoshida T. Primary biliary cirrhosis coexisting with sarcoidosis or possibly Sjögren's syndrome. West J Med 1991;154: 352-3.
171. Milosevic M, Adams P. Primary biliary cirrhosis and polymyositis. J Clin Gastroenterol 1990;12:332-5.
172. Wilson RA. Therapeutic quandary: Asymptomatic primary biliary cirrhosis associated with polymyositis. Dig Dis Sci 1981;26:372-5.
173. Leff JA, Ready JB, Repetto C, et al. Co-existence of primary biliary cirrhosis and sarcoidosis. West J Med 1990;153:439-41.
174. Goldenstein C, Rabson AR, Kaplan MM, et al. Arthralgias as a presenting manifestation of primary biliary cirrhosis. J Rheumatol 1989;16:681-4.
175. Liffe L, Naido S, Hunter T. Primary biliary cirrhosis associated with features of systemic lupus erythematosis. Dig Dis Sci 1982;27: 274-8.
176. Schumacher HR. Hemochromatosis and arthritis. Arthritis Rheum 1964;7:41-50.
177. Hamilton EBD, Bomford AB, Laws JW, et al. The natural history of arthritis in idiopathic hemochromatosis. Q J Med 1981;50:321-9.
178. Schumacher HR, Straka PC, Krikker MA, et al. The arthropathy of hemochromatosis: Recent studies. Ann NY Acad Sci 1988;526:224-33.
179. Faraawi R, Harm M, Kertesz A, et al. Arthritis in hemochromatosis. J Rheumatol 993;20:448-52.
180. Phelps G, Chapman I, Hall P, et al. Prevalence of genetic hemochromatosis among diabetic patients. Lancet 1989;i:233-4.
181. Olynyk J, Hall P, Ahren M, et al. Screening for genetic hemochromatosis in a rheumatology clinic. Aust N Z J Med 1994;24:22-5.
182. Pitt P, Mowat A, Williams R, et al. Hepatic hypertrophic osteoarthropathy and liver transplantation. Ann Rheum Dis 1994;53:338-40.
183. Vickers C, Herbert A, Neuberger J, et al. Improvement in hypertrophic hepatic osteoarthropathy after liver transplantation. Lancet 1988; 2:968.
184. Gibson TJ, Schumacher HR, Pascual E, et al. Arthropathy, skin and bone lesions in pancreatic disease. J Rheumatol 1975;2:7-13.
185. Van Klaveren RJ, de Mulder PHM, Boerbooms AMT, et al. Pancreatic carcinoma with polyarthritis, fat necrosis and high serum lipase and trypsin activity. Gut 1990;31:953-5.
186. Mullins GT, Caperton EM, Crespin SR, et al. Arthritis and skin lesions resembling erythema nodosum in pancreatic disease. Ann Intern Med 1968;68:75-87.
187. Virshup AM, Sliwinski AJ. Polyarthritis and subcutaneous nodules associated with carcinoma of the pancreas. Arthritis Rheum 1973;16: 388-92.
188. Tannenbaum H, Anderson LG, Schur PH. Association of polyarthritis, subcutaneous nodules, and pancreatic disease. J Rheumatol 1975; 2:14-20.
189. Reginato AJ, Schumacher HR, Allan DA, et al. Acute monoarthritis associated with lipid liquid crystals. Ann Rheum Dis 1985;44:537-43.
190. Norton WL, Ziff M. Electron microscopic observations on the rheumatoid synovial membrane. Arthritis Rheum 1966;9:589-610.
191. Boswell SH, Baylin GJ. Metastatic fat necrosis and lytic bone lesions in a patient with painless acute pancreatitis. Radiology 1973;16:388-92.
192. Tan A, Morm ME, Baker DA, et al. Pancreatitis arthritis syndrome. South Med J 1979;72:739-41.
193. Scharpelli DG. Fat necrosis of bone marrow in acute pancreatitis. Am J Pathol 1956;32:1077-87.
194. Gran JT, Husby G. Joint manifestations in gastro-intestinal diseases. I. Pathophysiological aspects, ulcerative colitis and Crohn's Disease. Dig Dis 1992;10:274-94.
195. Gran JT, Husby G. Joint manifestations in gastro-intestinal diseases. II. Whipple's disease, enteric infections, intestinal bypass operations, gluten-sensitive enteropathy, pseudomembranous colitis and collagenous colitis. Dig Dis 1992;10:295-312.
196. Parke AL. Gastrointestinal disorders in rheumatic diseases. Curr Opin Rheumatol 1992;4:68-75.
197. Leirisalo-Repo M. Enteropathic arthritis, Whipple's disease, juvenile spondyloarthropathy, and uveitis. Curr Opin Rheumatol 1994;6(4): 385-90.
198. Mielants H, Veys EM, De Vos M, et al. The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects. J Rheumatol 1995;22:2266-72.
199. Mielants H, Veys EM, Cuvelier C, et al. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. J Rheumatol 1995;22:2273-8.
200. Mielants H, Veys EM, Cuvelier C, et al. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. J Rheumatol 1995;22:2279-84.